Suggested benefits for mood, cognition, and possibly conditions like traumatic brain injury, Parkinsons disease, and depression, but these claims are not substantiated in humans358
This review highlights key clinical considerations across reproductive stages, emphasizes the primacy of human exposure data where available, and identifies critical evidence gaps requiring future prospective study
FOXO4-DRI represents a peptide-based senolytic approach that is more targeted than small-molecule senolytics like dasatinib plus quercetin, which affect broader cellular pathways
What does losing six to eight pounds in the first month suggest
Generally, transitions between GLP-1 agonists can be done without a washout period, though starting the new medication at a lower dose and titrating up is standard practice regardless of what you were taking before
The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells
